financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mastercard Insider Sold Shares Worth $9,781,694, According to a Recent SEC Filing
Mastercard Insider Sold Shares Worth $9,781,694, According to a Recent SEC Filing
Mar 6, 2025
04:10 PM EST, 03/06/2025 (MT Newswires) -- Michael Miebach, Director, President & CEO, on March 05, 2025, sold 17,664 shares in Mastercard ( MA ) for $9,781,694. Following the Form 4 filing with the SEC, Miebach has control over a total of 100,646 Class A common shares of the company, with 100,646 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1141391/000114139125000052/xslF345X05/wk-form4_1741294973.xml ...
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics
Mar 6, 2025
WASHINGTON, March 6 (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' ( SRDX ) acquisition by private equity firm GTCR, with the regulatory agency alleging the deal was anticompetitive. The FTC said the deal would create a combined company controlling more than 50% of the market for outsourced hydrophilic coatings. These...
Teva Pharmaceutical Industries Insider Sold Shares Worth $375,534, According to a Recent SEC Filing
Teva Pharmaceutical Industries Insider Sold Shares Worth $375,534, According to a Recent SEC Filing
Mar 6, 2025
04:10 PM EST, 03/06/2025 (MT Newswires) -- Richard D Francis, President and CEO, on March 04, 2025, sold 23,773 shares in Teva Pharmaceutical Industries ( TEVA ) for $375,534. Following the Form 4 filing with the SEC, Francis has control over a total of 271,783 common shares of the company, with 271,783 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000095017025034583/xslF345X05/ownership.xml ...
Mastercard Insider Sold Shares Worth $6,118,671, According to a Recent SEC Filing
Mastercard Insider Sold Shares Worth $6,118,671, According to a Recent SEC Filing
Mar 6, 2025
04:08 PM EST, 03/06/2025 (MT Newswires) -- Craig Vosburg, Chief Services Officer, on March 05, 2025, sold 11,002 shares in Mastercard ( MA ) for $6,118,671. Following the Form 4 filing with the SEC, Vosburg has control over a total of 63,074 Class A common shares of the company, with 63,074 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1141391/000114139125000053/xslF345X05/wk-form4_1741295016.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved